Skip to content
Home/Companies/Biotech/Oxford Cancer Analytics
OC

Oxford Cancer Analytics

Biotech·UK·Active·4yr hold

Oxford Cancer Analytics is a biotech company, headquartered in UK.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Oxford Cancer Analytics?

Oxford Cancer Analytics is currently owned by EKA Ventures through Eka Ventures Fund I (2021 vintage), since 2022.

Hand-verified · updated 2026-06-30

EKA Ventures
Investor
EKA Ventures
Eka Ventures Fund I · 2021 · Impact

Key facts

HQUK
SectorBiotech
StatusActive

More from Eka Ventures Fund I

Other portfolio companies in the same fund.

32Co
Active
HealthTechUK· 2024
Airhive
Active
ClimateTechUK· 2024
MakeSense
Active
MedTechUK· 2024
XRlabs
Active
MedTechUK· 2024
Axle
Active
EnergyUK· 2023
Isla
Active
HealthTechUK· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings